• Vor to Participate in Three Upcoming Investor Conferences

    Source: Nasdaq GlobeNewswire / 28 Feb 2022 07:00:02   America/Chicago

    CAMBRIDGE, Mass., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Vor Biopharma (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that members of its senior management team will be participating in three upcoming investor conferences:

    Cowen’s 42nd Annual Healthcare Conference
    Presentation Date: Monday, March 7, 2022
    Time: 2:10 PM ET

    Oppenheimer's 32nd Annual Healthcare Conference
    Presentation Date: Tuesday, March 15, 2022
    Time: 1:20 PM ET

    Barclays Global Healthcare Conference
    Fireside Chat: Thursday, March 17, 2022
    Time: 8:00 AM ET

    The live webcasts of the presentations and fireside chat will be available on the Company's website at www.vorbio.com. An archived replay of each webcast will also be available.

    About Vor Biopharma
    Vor Biopharma is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

    Contacts:

    Investors:
    Chris Brinzey
    ICR Westwicke
    +1 339-970-2843
    chris.brinzey@westwicke.com

    Media:
    Sarah Spencer
    Vice President, Corporate Communications, Vor
    +1 857-242-6076
    sspencer@vorbio.com

     


    Primary Logo

Share on,